-
公开(公告)号:AU7358700A
公开(公告)日:2001-04-10
申请号:AU7358700
申请日:2000-09-08
Applicant: ARIZONA BOARD OF REGENTS THE , BASF AG
Inventor: PETIT GEORGE R , SRIRANGAM JAYARAM K , WILLIAMS MICHAEL D , DURKIN KIERAN P M , BARLOZZARI TERESA , KLING ANDREAS , JANSSEN BERND , HAUPT ANDREAS
Abstract: The present invention provides compounds of the formulawhere R1-R5 are each, independently, a hydrogen atom or a normal or branched C1-C6-alkyl group; A is a methionyl, phenylalanyl or phenylglycyl residue; n is 0 or 1; R6 is a hydrogen atom; and R7 is a carbocylic group, an aromatic group, a C1-C4-alkyl group, a pyridylalkyl group or a heterocyclic group. In another embodiment, R6 is benzyl or -C(O)OR8, where R8 is a C1-C6-alkyl group, and R7 is a heteroaromatic group, such as a 2-thiazolyl group.
-
公开(公告)号:SK125199A3
公开(公告)日:2000-08-14
申请号:SK125199
申请日:1998-03-09
Applicant: BASF AG
Inventor: BARLOZZARI TERESA , HAUPT ANDREAS
IPC: A61K31/337 , A61K38/07 , A61K38/08 , A61K38/00 , A61K38/15 , A61P35/00 , C07K5/08 , C07K5/10 , C07K7/00 , A61K38/04
Abstract: The present invention provides compositions and methods for the treatment of cancer in a subject wherein compounds of Formula I as defined herein in combination with paclitaxel, taxotere or modified taxane or taxoid analogs provide enhanced anticancer effects over the effects achieved with the individual compounds.
-
公开(公告)号:GR3032630T3
公开(公告)日:2000-05-31
申请号:GR20000400328
申请日:2000-02-10
Applicant: BASF AG
Inventor: AMBERG WILHELM , BERNARD HARALD , BUSCHMANN ERNST , HAUPT ANDREAS , JANITSCHKE LOTHAR , JANSSEN BERND , KARL ULRICH , KLING ANDREAS , MUELLER STEFAN , DE POTZOLLI BERND , RITTER KURT , THYES MARCO , ZIERKE THOMAS
Abstract: PCT No. PCT/EP95/01577 Sec. 371 Date Nov. 4, 1996 Sec. 102(e) Date Nov. 4, 1996 PCT Filed Apr. 26, 1995 PCT Pub. No. WO95/30691 PCT Pub. Date Nov. 16, 1995The compound Me2Val-Val-MeVal-Pro-Pro-NHBzlxHCl is described. It is prepared from Z-Val-Val-MeVal-Pro-OR1 where Z and R1 have the meanings stated in the description. The compound shows antineoplastic activity.
-
公开(公告)号:TR200000132T2
公开(公告)日:2000-05-22
申请号:TR200000132
申请日:1998-07-07
Applicant: BASF AG
Inventor: JANSSEN BERND , BARLOZZARI TERESA , HAUPT ANDREAS , ZIERKE THOMAS , KLING ANDREAS
Abstract: Compounds of the present invention include cell growth inhibitors which are peptides of Formula I, A-B-D-E-F-(G)r-(K)s-L (I), and acid salts thereof, wherein A, B, D, E, F, G and K are α-amino acid residues, and s and r are each, independently, 0 or 1. L is a monovalent radical, such as, for example, an amino group, an N-substituted amino group, a &bgr;-hydroxylamino group, a hydrazido group, an alkoxy group, a thioalkoxy group, an aminoxy group, or an oximato group. The present invention also includes a method for treating cancer in a mammal, such as a human, comprising administering to the mammal an effective amount of a compound of Formula I in a pharmaceutically acceptable composition.
-
公开(公告)号:PT758342E
公开(公告)日:2000-04-28
申请号:PT95917963
申请日:1995-04-26
Applicant: BASF AG
Inventor: JANSSEN BERND , ZIERKE THOMAS , ERNST BUSCHMANN DR , AMBERG WILHELM , BERNARD HARALD , HAUPT ANDREAS , JANITSCHKE LOTHAR , KARL ULRICH , KLING ANDREAS , MULLER STEFAN , POTZOLLI BERND DE , RITTER KURT , THYES MARCO
Abstract: PCT No. PCT/EP95/01577 Sec. 371 Date Nov. 4, 1996 Sec. 102(e) Date Nov. 4, 1996 PCT Filed Apr. 26, 1995 PCT Pub. No. WO95/30691 PCT Pub. Date Nov. 16, 1995The compound Me2Val-Val-MeVal-Pro-Pro-NHBzlxHCl is described. It is prepared from Z-Val-Val-MeVal-Pro-OR1 where Z and R1 have the meanings stated in the description. The compound shows antineoplastic activity.
-
公开(公告)号:PL178351B1
公开(公告)日:2000-04-28
申请号:PL30620893
申请日:1993-05-10
Applicant: BASF AG
Inventor: HAUPT ANDREAS , EMLING FRANZ , ROMERDAHL CYNTHIA
Abstract: 1. The peptide with the formula I where: R1> refers to a C1-7-alkyl group, C3-6-cycloalkyl group, R2> refers to an atom of hydrogen, C1-4-alkyl group, R1>-N-R2> together refer to an N-pyrrolidinyl group, A refers to valyl radical, isoleucil radical, 2-tert-butyl-glycil radical or 2-ethyl-glycil radical, B refers to N-methyl- or N-ethyl-valyl radical, norvalyl, leucil, isoleucil, 2-tert-butyl-glycol, 3-tert-butyl-alanyl radical, D and E refer to a radical selected independently from the group of radicals: prolyl, homo-prolyl, hydroxy-prolyl or thiazolidinyl-4-carbonyl; F and G refer to a radical selected independently from the group of radicals: valyl, 2-tert-butyl-glycil, isoleucil, leucil, 3-cyclohexyl-alanyl, phenyl-alanyl, N-methyl-phenyl-alanyl, tetra-hydro-iso-quinolyl-2-carbonyl, 1-aminoindole-1-carbonyl and 3-naphthyl-alanyl, X refers to a C1-5-alkyl group, v and w are independently equal to 0 or 1, while K refers to OH group, C1-7-alkoxyl group, phenoxyl group, or an amino radical with the formula R5>-N-R6>, where: R5> refers to an atom of hydrogen, or a hydroxyl group or a C1-7-alkoxyl group or benzyloxyl group or C1-7-alkyl group or fluorine-alkyl group or C3-7-cycloalkyl group or benzyl group, which can be substituted with three substituents at most, while the substituents may refer independently to CF3, nitric group, C1-7-alkyl-sulphonyl group, C1-4-alkoxyl group, phenoxyl group, benzoxyl group, a halogen or a C1-4-alkyl group; R6> refers to an atom of hydrogen or C1-7-alkyl group C3-7-cycloalkyl group or fluorine-alkyl group or phenyl group, which can be substituted with three substituents at most, while the substituents may refer independently to a CF3 group, nitric group, C1-4-alkyl group - which can form a cyclical configuration - C1-4-alkoxyl group, phenoxyl group, benzoxyl group or C1-7-alkyl-sulphonyl group...
-
公开(公告)号:CZ321399A3
公开(公告)日:2000-04-12
申请号:CZ321399
申请日:1998-03-05
Applicant: BASF AG
Inventor: RITTER KURT , AMBERG WILHELM , BARLOZZARI TERESA , HAUPT ANDREAS , JANNSEN BERN , KLING ANDREAS
-
公开(公告)号:NO20001758D0
公开(公告)日:2000-04-05
申请号:NO20001758
申请日:2000-04-05
Applicant: BASF AG
Inventor: BARLOZZARI TERESA , BANERJEE SUBHASHIS , HAUPT ANDREAS
Abstract: The present invention provides compositions and methods for the treatment of rheumatoid arthritis in a subject wherein one or more compounds of Formula I as defined herein alone or in combination with one or more other antiarthritic drugs provide suppression of rheumatoid arthritis.
-
公开(公告)号:BR9609424A
公开(公告)日:2000-03-28
申请号:BR9609424
申请日:1996-06-03
Applicant: BASF AG
Inventor: HAUPT ANDREAS , EMLING FRANZ , ROMERDAHL CYNTHIA A
Abstract: Novel compounds of the formulaR1R2N-CHX-CO-A-B-D-(E)s-(F)t-(G)U-KIin which R1, R2, A, B, D, E, F, G, K, X, s, t, and u have the meanings stated in the description, and the preparation thereof are described. The novel substances have an antineoplastic effect.
-
公开(公告)号:ES2141351T3
公开(公告)日:2000-03-16
申请号:ES95917963
申请日:1995-04-26
Applicant: BASF AG
Inventor: AMBERG WILHELM , BERNARD HARALD , BUSCHMANN ERNST , HAUPT ANDREAS , JANITSCHKE LOTHAR , JANSSEN BERND
Abstract: PCT No. PCT/EP95/01577 Sec. 371 Date Nov. 4, 1996 Sec. 102(e) Date Nov. 4, 1996 PCT Filed Apr. 26, 1995 PCT Pub. No. WO95/30691 PCT Pub. Date Nov. 16, 1995The compound Me2Val-Val-MeVal-Pro-Pro-NHBzlxHCl is described. It is prepared from Z-Val-Val-MeVal-Pro-OR1 where Z and R1 have the meanings stated in the description. The compound shows antineoplastic activity.
-
-
-
-
-
-
-
-
-